Alerts will be sent to your verified email
Verify Email
KPL
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Kwality Pharmaceuticals Ltd. is a pharmaceutical formation company manufacturing and exporting finished pharmaceutical formulations in various dosage forms since 1983, following new GMP norms.
Kwality Pharma major competitors are Lincoln Pharma, Bharat Parenterals, Wanbury, Anuh Pharma, Ind-Swift Lab., Sakar Healthcare, Shivalik Rasayan.
Market Cap of Kwality Pharma is ₹1,028 Crs.
While the median market cap of its peers are ₹875 Crs.
Kwality Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Dec | Mar Jun Sep | ||||||||||||||||
| Investor Presentation | Jun | Mar May | Mar Jun | Mar May | ||||||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
